Latest news
Lilly Boosts Sales Guidance on Strong Demand for Obesity Drugs - Bloomberg.comBloomberg.com · Wed, 05 Aug 2026 13:38:04 GMTRecon: Lilly to broaden expanded access for unapproved obesity drug; Jazz to withdraw second-line SCLC indication for Zepzelca - RAPSRAPS · Tue, 04 Aug 2026 20:19:00 GMTEli Lilly will offer experimental obesity drug early to some patients. Who qualifies? - Houston ChronicleHouston Chronicle · Tue, 04 Aug 2026 19:37:30 GMTRhythm Pharma's obesity drug shows promise for brain tumor-related weight condition - TradingViewTradingView · Tue, 04 Aug 2026 12:28:27 GMTEli Lilly’s obesity drugs fuel revenue growth as demand shows no sign of slowing down - RSM UKRSM UK · Tue, 04 Aug 2026 07:00:00 GMTEmployers Are Trimming Obesity Drug Benefits for Workers, Cigna Says - Bloomberg.comBloomberg.com · Thu, 30 Jul 2026 07:00:00 GMTObesity Drugs Show Varying Benefits, Risks, and Discontinuation Rates - Docwire NewsDocwire News · Tue, 28 Jul 2026 07:00:00 GMT